Clinical trial
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
NCT00004092
Study timeline
Study start (unknown)1999-05-01Date precision: month
Registry last updated2015-08-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
filgrastimBIOLOGICAL
carboplatinDRUG · verified · RxNorm: carboplatin
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
paclitaxelDRUG · verified · RxNorm: paclitaxel
thiotepaDRUG · verified · RxNorm: thiotepa
Sponsors & collaborators
City of Hope Medical Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00004092 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.